In addition, anthocyanins inhibit low‐grade chronic inflammation by inhibiting the inflammatory mediators TNF‐α, IL‐6, and NF‐κB signaling pathways implicated in the progression of type 2 diabetes. This evidence concerns the gene IL6 and type 2 diabetes mellitus.